FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Wor.Bul.Pub.Helt. 2022;8:67-72. Accessed April 18, 2026. https://www.scholarexpress.net/index.php/wbph/article/view/651